Unknown NA INTERVENTIONAL 1-arm NCT04758481

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy of All Body Locations With the Disease at 3 Months After First Line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer, Prior to Maintenance Therapy

Sponsor: University Hospital Ostrava

Conditions Non-small Cell Lung Cancer

Interventions maintenance radiotherapy primary tumour radiotherapy stereotactic body radiotherapy

Updated 5 times since 2021 Last updated: Dec 6, 2022 Started: May 4, 2021 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Non-small Cell Lung Cancer, this trial is ongoing. The trial is conducted by University Hospital Ostrava and has accumulated 5 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jan 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Mar 2021 — Jan 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Ostrava

Data source: University Hospital Ostrava

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ostrava, Czechia